Correlation of miR-425-5p and IL-23 with pancreatic cancer
Authors:
Open Access
- 4 March 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (5) , 4595-4599
Abstract
The aim of this study was to detect the levels of miR-425-5p and IL-23 in tissues of pancreatic cancer patients and to explore their effects on pancreatic cancer. A retrospective analysis of 76 cases of pancreatic cancer tissue specimens and normal fresh tissue specimens at 50 mm adjacent to the corresponding cancer surgically resected in the first diagnosis was performed, in the Department of Radiotherapy of Traditional Chinese Medical Hospital of Huangdao District and Weifang Medical University Hospital from October 2015 to October 2016. RT-qPCR was used to detect miR-425-5p levels in pancreatic cancer and adjacent tissues, and ELISA to detect IL-23 levels in the tissues. The correlation of miR-425-5p and IL-23 in pancreatic cancer tissues with clinicopathological parameters was analyzed. The expression levels of miR-425-5p and IL-23 were significantly higher in pancreatic cancer tissues than those in adjacent tissues, with statistically significant difference (P<0.001). The expression level of miR-425-5p was positively correlated with IL-23 in pancreatic cancer tissues (r=0.432, P<0.001), and of miR-425-5p in tumor tissues of pancreatic cancer patients was correlated with lymph node metastasis, clinical stage and differentiation degree (P<0.001). That of IL-23 in tumor tissues of pancreatic cancer patients was correlated with clinical stage (P<0.001). The expression levels of miR-425-5p and IL-23 in tissues of pancreatic cancer patients are higher than those in adjacent tissues. The expression level of miR-425-5p is positively correlated with that of IL-23 in pancreatic cancer tissues, and that of miR-425-5p in tumor tissues of pancreatic cancer patients was correlated with lymph node metastasis, clinical stage and differentiation degree. IL-23 in tumor tissues of pancreatic cancer patients was correlated with clinical stage. miR-425-5p and IL-23 may be involved in the pathological development of pancreatic cancer.Keywords
This publication has 23 references indexed in Scilit:
- Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines2010
- IL-23 Drives Pathogenic IL-17-Producing CD8+ T CellsThe Journal of Immunology, 2009
- Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory PathwayThe Journal of Immunology, 2008
- ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.2008
- Radical resection of pancreatic cancer.2008
- IL-23 promotes tumour incidence and growthNature, 2006
- Epidemiology and risk factors for pancreatic cancerBest Practice & Research Clinical Gastroenterology, 2006
- Pancreatic cancerThe Lancet, 2004
- Long-Term Survival After Radical Resection of Advanced Pancreatic Cancer: A Case Report With Special Reference to CD8+ T-Cell InfiltrationJournal of Gastrointestinal Cancer, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001